Skip to main content
VCbacked
Log inGet Started

Spark Biomedical

Houston, United States

Spark Biomedical, Inc. is a medical device company developing non-invasive neurostimulation solutions for opioid withdrawal and addiction.

$15.0M raised
Apr 2025
Series A
Health CareMedical DeviceTherapeutics

Top Investors

National Institute on Drug Abuse (NIDA)Pathway to CuresWAVE VenturesTexas A&M Innovation

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Spark Biomedical

How much funding has Spark Biomedical raised?
Spark Biomedical has raised $15.0M in total funding. The most recent round was Series A. The last funding was announced in April 2025.
Who are Spark Biomedical's investors?
Spark Biomedical's investors include National Institute on Drug Abuse (NIDA), Pathway to Cures, WAVE Ventures, Texas A&M Innovation.
Where is Spark Biomedical headquartered?
Spark Biomedical is headquartered in Houston, United States.
What does Spark Biomedical do?
Spark Biomedical, Inc. is a medical device company developing non-invasive neurostimulation solutions for opioid withdrawal and addiction.
What stage is Spark Biomedical at?
Spark Biomedical is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Spark Biomedical — Funding & Investors." VCBacked, April 29, 2025, https://www.vcbacked.co/company/spark-biomedical. Accessed June 17, 2026.
APA
VCBacked. (2025). Spark Biomedical — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/spark-biomedical
Wikipedia (cite web)
{{cite web |title=Spark Biomedical — Funding & Investors |url=https://www.vcbacked.co/company/spark-biomedical |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Virtuoso Surgical
Nashville
Basata
Phoenix
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Sedivention
Munich$848K